These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3019252

  • 1. [A phase II study of epirubicin in advanced lung cancer].
    Furuse K, Fukuoka M, Yamamoto M, Kawahara M, Tsuruta M, Kodama N, Arai R, Hayashi S, Kiyota M, Kubota K.
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2835-40. PubMed ID: 3019252
    [Abstract] [Full Text] [Related]

  • 2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Sep; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 3. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
    Kimura K, Wakui A, Saito T, Tominaga T, Niitani H, Fujimoto T, Masaoka T, Toki H, Tamura K.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
    [Abstract] [Full Text] [Related]

  • 4. Preliminary phase II study of adriamycin (ADM) in patients with non-small cell lung cancer (NSCLC).
    Fujita J, Saijo N, Eguchi K, Shinkai T, Tominaga K, Sasaki Y, Sakurai M, Futami H, Ishihara J, Takahashi H.
    Jpn J Clin Oncol; 1985 Jun; 15(2):365-8. PubMed ID: 4021119
    [Abstract] [Full Text] [Related]

  • 5. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M, Oshima S, Matsui Y, Shimokata K, Hara K, Kanda T, Shima K, Takenaka S.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [Abstract] [Full Text] [Related]

  • 6. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
    Kimura K, Suga S, Kano H, Sakakibara K, Hayashi T, Nakai T, Nagano I, Yokoyama Y, Morise K, Hayakawa M.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
    Niijima T, Koyanagi T, Maru A, Sakashita S, Koiso K, Ishikawa H, Uchida K, Shimazaki J, Isaka S, Akaza H.
    Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of vindesine in patients with non-small cell lung cancer.
    Fujita J, Saijo N, Eguchi K, Shinkai T, Tominaga K, Sasaki Y, Futami H, Sakurai M, Ishihara J, Takahashi H.
    Jpn J Cancer Res; 1985 Sep; 76(9):902-5. PubMed ID: 2997097
    [Abstract] [Full Text] [Related]

  • 10. [A phase II study of NK171 (etoposide)].
    Kimura K, Niitani H.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [Abstract] [Full Text] [Related]

  • 11. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
    Furuse K, Fukuoka M, Kurita Y, Ariyoshi Y, Niitani H, Yoneda S, Fujii M, Hasegawa K, Nishiwaki Y, Tamura M.
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):879-84. PubMed ID: 1318698
    [Abstract] [Full Text] [Related]

  • 12. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of epirubicin given on a weekly schedule.
    Snyder R, Bishop J, Brodie G, Burns W, Coates A, Levi J, Raghavan D, Schwarz M, Tattersall M, Thomson D.
    Cancer Treat Rep; 1987 Mar; 71(3):273-6. PubMed ID: 3028619
    [Abstract] [Full Text] [Related]

  • 14. [A phase II study of epirubicin in malignant lymphoma].
    Masaoka T, Shibata H, Sampi K, Hirota Y, Yoshida Y, Chiba Y, Shirakawa S, Kobayashi T, Toki H, Tamura K.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2606-11. PubMed ID: 3461747
    [Abstract] [Full Text] [Related]

  • 15. [A phase II study of carboplatin in small cell lung cancer].
    Komatsu H, Furuse K, Nishikawa H, Minoda S, Saotome K, Nemoto E, Tani Y, Saito T, Ishiwata K, Tsutsumi M.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2313-8. PubMed ID: 2841905
    [Abstract] [Full Text] [Related]

  • 16. [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
    Sakata Y, Yoshida Y.
    Gan To Kagaku Ryoho; 1986 May; 13(5):1887-92. PubMed ID: 3458431
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 19. [A phase II study of vindesine for pretreated non-small cell lung cancer].
    Shimizu E, Nakamura Y, Yamasaki K, Kimura K, Inoue I, Nakahira S, Kawahito K, Tani K, Sone S, Yamashita T.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
    [Abstract] [Full Text] [Related]

  • 20. [Phase II study of cis-dichlorodiammineplatinum (II) for non-small cell lung cancer].
    Fukuoka M, Furuse K, Takada M, Negoro S, Tamai S, Matsui K, Sakai N, Ryu S, Yoshinaga T, Kawahara M.
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):471-8. PubMed ID: 2988455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.